Since the 21st century, target-based drug discovery has increasingly replaced traditional structure-based approaches, becoming the dominant strategy in modern drug development. The success of targeted drug development hinges on high-quality, stable recombinant target proteins. As cornerstones of biopharmaceutical R&D, these proteins' quality directly impacts screening accuracy and evaluation reliability.

Creative Biogene delivers an extensive portfolio of recombinant drug target proteins with exceptional batch-to-batch consistency, leveraging advanced expression systems and optimized post-translational modifications. Our comprehensive protein collection, manufactured under global pharmacopeia standards and supported by a traceable supply chain, ensures reliable delivery of premium-grade products that meet diverse requirements across the drug development pipeline, from research to GMP-grade levels.